(Press-News.org) Contact information: Julie Langelier
julie.langelier@ircm.qc.ca
514-987-5555
Institut de recherches cliniques de Montreal
The importance of standardizing drug screening studies
An IRCM researcher sheds light on inconsistencies between large pharmacogenomic studies
Montréal, December 2, 2013 – A bioinformatics expert at the IRCM, Benjamin Haibe-Kains, recently published an article stressing the importance of standardizing drug screening studies in the prestigious scientific journal Nature. The study supports the need for further development and standardization to improve the reproducibility of drug screening studies, as they are important in identifying new therapeutic agents and their potential combinations with existing drugs.
Dr. Haibe-Kains's article investigated results from two large-scale pharmacogenomic studies – the Cancer Genome Project (CGP) and the Cancer Cell Line Encyclopedia (CCLE) – published last year in Nature. The main goal of these studies was to identify genomic biomarkers that could predict patients' response to anticancer drugs. Because cancer patients often exhibit varied responses to anticancer treatments, and evidence indicates that response is determined in part by patient-specific genome alterations, cancer cell line studies have long been used to test the efficacy of therapeutic agents and explore genomic factors associated with drug response. These two studies screened multiple new and approved drugs on nearly 1,000 panels of cancer cell lines, of which 15 drugs and 471 cell lines were common.
"These studies provided us with a unique opportunity to look at the reproducibility of biomarker discovery in preclinical settings," says Dr. Haibe-Kains, Director of the Bioinformatics and Computational Biology research unit at the IRCM. "Our objective was to examine the uniformities and inconsistencies between results from the two independent studies, and assess the potential of building predictive models of drug response on the basis of those results."
Dr. Haibe-Kains and his research team observed overall good consistency of genomic profiles, which contain information about all the genes in the body and can be used to determine response to a drug. However, drug sensitivity measurements used in the two studies were highly inconsistent.
"We believe the reasons for such differences include the lack of standardization in experimental assays and data analysis methods," adds Dr. Haibe-Kains. "For example, the studies tested different drug concentrations and used different statistical models to analyze their data. In addition, due to discrepancies in drug sensitivity data, some potential biomarkers were inconsistent between the two studies."
"These pharmacogenomic studies are generally the first step in a larger experimental pipeline where candidate drugs and biomarkers are further validated in animal studies and human clinical trials," explains Dr. Haibe-Kains. "Our findings support the need for standardization of drug-response measurements or the development of new, robust drug sensitivity assays in order to identify reliable genomic predictors of drug response or effectively identify a drug's mechanism of action."
"It is important to note that our study and the resulting observations could not have been possible if the data had not been well documented and made accessible to the scientific community," concludes Dr. Haibe-Kains. "This represents a big success for open data science and reproducible research, and we would like to thank the investigators from the CGP and CCLE studies who made their invaluable data available to researchers everywhere. Without this data, we would not have been able to discover the discrepancies. We now need to work together to improve the reproducibility of large-scale screening studies so that we can identify new therapeutic agents and their potential combinations with existing drugs."
###
The study was conducted in collaboration with Nehme El-Hachem from the IRCM, and researchers from the Technical University of Denmark and the Dana Farber Cancer Institute in Boston.
For more information, please refer to the article summary published online by Nature: http://www.nature.com/nature/journal/vaop/ncurrent/full/nature12831.html#access.
About the IRCM
Founded in 1967, the Institut de recherches cliniques de Montréal is currently comprised of 36 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses four specialized research clinics, eight core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University. The IRCM is funded by the Quebec ministry of Higher Education, Research, Science and Technology.
The importance of standardizing drug screening studies
An IRCM researcher sheds light on inconsistencies between large pharmacogenomic studies
2013-12-02
ELSE PRESS RELEASES FROM THIS DATE:
Nanorobot for transporting drugs in the body
2013-12-02
Nanorobot for transporting drugs in the body
A nanorobot is a popular term for molecules with a unique property that enables them to be programmed to carry out a specific task. In collaboration with colleagues in Italy and the USA, researchers at Aarhus University have ...
New report illustrates persistent global burden of anemia among high-risk populations
2013-12-02
New report illustrates persistent global burden of anemia among high-risk populations
(WASHINGTON, December 2, 2013) – Despite increasing efforts to diagnose and treat anemia worldwide, there remains a surprisingly large global burden of the disease, particularly ...
Researchers unlock a new means of growing intestinal stem cells
2013-12-02
Researchers unlock a new means of growing intestinal stem cells
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes
CAMBRIDGE, MA -- Researchers at MIT and Brigham and Women's Hospital have shown ...
Mice can inherit learned sensitivity to a smell
2013-12-02
Mice can inherit learned sensitivity to a smell
Trauma can scar people so indelibly that their children are affected. History provides examples of generations traumatized by war and starvation, whose children experience altered physiology.
Now researchers at Yerkes ...
Forget the needle consider the haystack
2013-12-02
Forget the needle consider the haystack
Uncovering hidden structures in massive data collections
Advances in computer storage have created collections of data so huge that researchers often have trouble uncovering critical patterns in connections ...
Living with chronic pain: The daily struggle with a 'new self'
2013-12-02
Living with chronic pain: The daily struggle with a 'new self'
People who suffer with chronic musculoskeletal pain face a daily struggle with their sense of self and find it difficult to prove the legitimacy of their condition.
A new study, funded by the National Institute ...
Oxygen levels increase and decrease the effectiveness of anti-inflammatory therapies
2013-12-02
Oxygen levels increase and decrease the effectiveness of anti-inflammatory therapies
New research published in the Journal of Leukocyte Biology suggests that the effectiveness of anti-inflammatory glucocorticoids may be related to ...
Understanding hearing
2013-12-02
Understanding hearing
Computer models of neuronal sound processing in the brain lead to cochlear implant improvements
This news release is available in German.
Intact hearing is a prerequisite for learning to speak. This is why children ...
Newly discovered human peptide may become a new treatment for diabetes
2013-12-02
Newly discovered human peptide may become a new treatment for diabetes
New research in The FASEB Journal suggests that humanin, a peptide produced by the human body, increases the metabolism of glucose in beta cells, which in turn ...
Salk scientists crack riddle of important drug target
2013-12-02
Salk scientists crack riddle of important drug target
New method for determining structure of key cellular receptors could speed drug development
LA JOLLA, CA---- A new approach to mapping how proteins interact with each other, developed at the Salk Institute for Biological Studies, ...
LAST 30 PRESS RELEASES:
Garment factories are sweltering. These simple fixes could keep workers safe
‘Slums’ of Victorian Manchester housed wealthy doctors and engineers, new study reveals
Winners of Applied Microbiology International Horizon Awards 2025 announced
Most of Wine Country’s agricultural workers have been exposed to wildfires, new survey finds
Obesity-related cancer rising among both younger and older adults worldwide
A 'Rosetta Stone' for molecular systems
What goes up must come down – scientists unearth “universal thermal performance curve” that shackles evolution
Physical activity increases total daily energy use, study shows
National study finds public Montessori programs strengthens early learning outcomes -- at sharply lower costs compared to traditional preschool
National poll: 1 in 10 young children play outdoors as little as once a week
How do people learn new facts?
Exploring how storytelling strategies shape memories
How people process mental images versus real-life visuals
Blood test could help predict blood pressure after weight loss surgery in teens
Ultra-endurance athletes test the metabolic limits of the human body
Revealing the 'carbon hoofprint' of meat consumption for American cities
Like radar, a brain wave sweeps a cortical region to read out information held in working memory
Resistance to epilepsy treatments may wane over time
Precision reprogramming: How AI tricks cancer’s toughest cells
US physician Medicare program participation and exit, 2013-2023
A direct-to-patient digital health program for lung cancer screening
Belgian scientists discover how cells protect our skin from inflammatory disease – paving the way for new treatments
Effectiveness of colchicine for the treatment of long COVID
Distance to care and telehealth abortion demand after Dobbs
Epidural electrical stimulation for functional recovery in incomplete spinal cord injury
Transformative eye research expands donor pool for corneal transplant patients
Retinal implant restores central vision in patients with advanced AMD, study co-led by Pitt investigator shows
Eye prosthesis is the first to restore sight lost to macular degeneration
Pioneering eye device restores reading vision to blind eyes
Subretinal implant partially restores vision in AMD patients
[Press-News.org] The importance of standardizing drug screening studiesAn IRCM researcher sheds light on inconsistencies between large pharmacogenomic studies